Cargando…
Functional observation after morphine withdrawal: effects of SJP-005
RATIONALE AND OBJECTIVE: SJP-005 (ketotifen and ibuprofen) is being developed as a potential new treatment for opioid withdrawal. Three studies were conducted to evaluate the early phase (acute, day 1) and late phase (days 2–12) effects of SJP-005 on discontinuation-induced morphine withdrawal. METH...
Autores principales: | Verster, Joris C., Scholey, Andrew, Dahl, Thomas A., Iversen, Jacqueline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139893/ https://www.ncbi.nlm.nih.gov/pubmed/33555386 http://dx.doi.org/10.1007/s00213-021-05771-5 |
Ejemplares similares
-
A Comparison of the Antinociceptive Properties of SJP-005 and Morphine in Rats
por: Verster, Joris C, et al.
Publicado: (2021) -
The Effects of SJP-001 on Alcohol Hangover Severity: A Pilot Study
por: Verster, Joris C, et al.
Publicado: (2020) -
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
por: Kiani, Pantea, et al.
Publicado: (2022) -
The Efficacy of the Combination of Naproxen and Fexofenadine (SJP-003) to Prevent or Reduce Side Effects of Receiving Multiple Travel Vaccines: A Case Report
por: Kiani, Pantea, et al.
Publicado: (2022) -
The efficacy of a combination of naproxen and fexofenadine (SJP − 002) to inhibit the symptoms that are associated with viral upper respiratory tract infection: Four case reports of individuals with common cold
por: Išerić, Emina, et al.
Publicado: (2023)